| Title: | Identifying cross-disease components of genetic risk across hospital data in the UK Biobank |
| Journal: | Nature Genetics |
| Published: | 23 Dec 2019 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/31873298/ |
| DOI: | https://doi.org/10.1038/s41588-019-0550-4 |
| URL: | https://europepmc.org/articles/pmc6974401?pdf=render |
Publication 5178
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Genetic risk factors frequently affect multiple common human diseases, providing insight into shared pathophysiological pathways and opportunities for therapeutic development. However, systematic identification of genetic profiles of disease risk is limited by the availability of both comprehensive clinical data on population-scale cohorts and the lack of suitable statistical methodology that can handle the scale of and differential power inherent in multi-phenotype data. Here, we develop a disease-agnostic approach to cluster the genetic risk profiles for 3,025 genome-wide independent loci across 19,155 disease classification codes from 320,644 participants in the UK Biobank, representing a large and heterogeneous population. We identify 339 distinct disease association profiles and use multiple approaches to link clusters to the underlying biological pathways. We show how clusters can decompose the variance and covariance in risk for disease, thereby identifying underlying biological processes and their impact. We demonstrate the use of clusters in defining disease relationships and their potential in informing therapeutic strategies.5 Authors
- Adrian Cortes
- Patrick K. Albers
- Calliope A. Dendrou
- Lars Fugger
- Gil McVean
Enabling scientific discoveries that improve human health